via Yale University
Daniel Wiznia, MD, an orthopaedic surgeon with Yale School of Medicine, is practicing a surgical technique designed to render 10% of hip replacements unnecessary. Regenerative properties from a patient’s own stem cells are responsible for regrowing bone, restoring blood flow, and being able to avoid further interventional surgery.
Osteonecrosis, also known as avascular necrosis, occurs in more than 20,000 Americans each year. As the condition progresses, bone cells known as osteoblasts become unable to repair themselves and sustain the integrity of the bone, and ultimately die. The bone deterioration leads to a decrease in blood flow to the area, further weakening the entire skeletal structure of the upper leg. If unaddressed, the ball portion of the hip’s ball and socket joint will cave in on itself and collapse, requiring a total hip replacement.
The fact that patients often receive this diagnosis during their 30s and 40s presents a particular challenge. While the lifespan of hip prosthetics has dramatically increased in recent years, a patient who undergoes a total hip arthroplasty, or total hip replacement, at that age will almost certainly require a revision later in life. This redo of the same surgery at an older age comes with an entirely new set of risks and potential complications, making it that much harder to manage down the road.
The goal in patients with this condition then becomes very clear: prevent the head of the femur (thighbone) from collapsing.
Wiznia, assistant professor of orthopaedics and rehabilitation, and of mechanical engineering and materials science, draws from both of those areas of expertise to use 3D imaging technology as part of an innovative joint-preservation procedure. In recent years, he has worked closely with the Yale School of Engineering & Applied Sciences and the Integrated 3D Surgical Team at the Yale School of Medicine to tailor this treatment to each patient. Imaging has proven to be critical to the successful outcome of this surgical technique.
“One of the challenges of orthopaedic surgery in the human body is that surgeons are operating in a three-dimensional space and are often reliant on two-dimensional imagery such as X-rays,” Wiznia says. “Through computer modeling, we are able to customize those images and create models that are specific to each patient, which, in turn, enhances outcomes and overall post-operative success rates.”
Wiznia surgically harvests bone marrow from the patient’s pelvis. By using a centrifuge inside the operating room, he is able to isolate and concentrate the individual’s own stem cells. Material containing the stem cells is then injected into the area of bone that has died.
Research has shown that stem cells possess the characteristics and qualities needed for the body to regrow, repair, and regenerate damaged tissue and bone, and according to Wiznia, this treatment dramatically reduces the risk of the head of the femur from collapsing. Soon after the procedure, many patients with avascular necrosis experience rejuvenated blood supply to the area and the bone is repopulated with new cells. This can additionally alleviate the short-term need for a hip replacement.
The major challenge in this patient population is identifying, diagnosing, and performing surgical intervention in time before the collapse. “Because the vascular injury is usually a painless event,” says Wiznia, “patients are generally unaware of the specific point in time when the injury occurred, which is why cases are rarely discovered in time.”
Patients may be encouraged to know that those who have avascular necrosis of the hip generally have it present on both sides, and it can develop on the two sides at different rates. So, even if it is detected too late on one side, there is still a chance to preserve the other.
“We usually are able to catch that second asymptomatic side in those situations and conduct the core decompression with stem cell treatment before it collapses,” Wiznia says. “This novel stem cell therapy has demonstrated improved pain and function, and the stem cells decrease the risk of the femoral head from collapsing. That ultimately translates into fewer young patients requiring hip replacements along with subsequent surgeries in their later years.”
Original Article: Stem Cell Therapy Reduces Need for Nearly 10% of Hip Replacements
More from: Yale School of Medicine
The Latest on: Stem cell therapy
- 'I can consider myself cancer free': Immunotherapy proves game-changing cancer treatment for patienton May 27, 2022 at 8:20 pm
“The worst is that it killed my white cells. I got to the limit [with just enough white cells] to be alive. I had to delay my treatment a couple of times to give my body time to recover,” she said.
- Off-The-Shelf, Targeted Engineered Stem Cell Therapy for Glioblastoma Keeps Mice Aliveon May 20, 2022 at 5:00 am
Researchers hope to start Phase I trials with the encapsulated engineered stem-cell therapeutic within two years.
- Pre-made stem cells may be pulled off the shelf to treat aggressive canceron May 19, 2022 at 7:56 pm
Stem cells that can be engineered to take on different properties continue to show huge potential in all areas of medicine, ranging from Parkinson's disease treatments to regenerative therapies for ...
- Parkinson’s: Promising stem cell treatment reverses symptoms in rodentson May 19, 2022 at 12:00 pm
A promising new stem cell treatment has reversed motor symptoms of Parkinson's in rats, paving the way for human trials.
- “Off the Shelf” Engineered Stem Cells Created To Treat Aggressive Brain Canceron May 19, 2022 at 2:02 am
Investigators uncovered a diagnostic method to identify receptors on cancer cells in the blood, then engineered a cell-based therapy to target and kill tumor cells in the brain, paving the way to ...
- Six Things to Know About Stem Cell Treatmenton May 13, 2022 at 8:53 am
Stem cell treatment is an alternative medical approach for various health conditions. It involves using stem cells to prevent, treat, or manage different diseases. But before you consider stem cell ...
- Stem cell therapy offers a new hope to repair brain damage in newbornson May 12, 2022 at 6:09 am
No therapy exists for newborns with stroke. Researchers, including our own team at University Medical Center Utrecht, have been working on new treatments, one of which involves stem cells.
- Stem cell therapy offers a new hope to repair brain damage in newbornson May 12, 2022 at 1:35 am
No therapy exists for newborns with stroke. Researchers, including our own team at University Medical Center Utrecht, have been working on new treatments, one of which involves stem cells. Stem cells ...
- Stem cell therapy protects against the side effects of cancer drugson May 5, 2022 at 6:45 am
Now, researchers from Osaka University have discovered that stem cell therapy may protect against such side effects. Type 1 diabetes is a serious autoimmune disease that develops when the level of ...
- Stem cell therapy protects against the side effects of cancer drugson May 4, 2022 at 5:01 pm
Now, researchers from Osaka University have discovered that stem cell therapy may protect against such side effects. One strategy by which tumor cells evade recognition by the immune system is by ...
via Bing News
The Latest on: Stem cell therapy
via Google News